Illinois Department of Healthcare and Family Services Drugs and Therapeutics Advisory Board met April 6.
Here is the agenda provided by the board:
I. Call to Order
II. Roll Call
III. Welcome
IV. Agenda and Conflict of Interest Review
V. Approval of the Minutes
VI. Public Comments
VII. PDL Drug Appeals
a. None at this meeting
VIII. New Drug Appeals
a. Perseris
IX. Drug Class Review- Ryan Rodriguez, PharmD Clinical review (with discussion and vote)
a. CPRG for Migraine
b. Oral Antipsychotics
X. New Drug Initial Review-Ryan Rodriguez, PharmD (with discussion and vote)
a. Tzield
b. Briumvi
c. Sunlenca
XI. Future Agenda Preview -Sheri Dolan
XII. Provider Requested Reviews-Sheri Dolan
a. Albuterol Syrup
b. Hepatitis C PDL Proposal
XIII. Department Update-Jose Jimenez
XIV. Adjournment
https://hfs.illinois.gov/content/dam/soi/en/web/hfs/sitecollectiondocuments/DTAdvisoryBoardAgenda04062023.pdf
Alerts Sign-up